DANISH BIO – DANSK BIOTEK organizes four major plenary meetings for our members throughout the year to increase our members' knowledge regarding specific biotech topics and to facilitate networking. The events usually take place in February, May, September and November.

We also organize approximately four "saloon" meetings annually. They are small, intimate, "meet the expert" meetings with typically 6-20 participants advocating more in-depth discussion and knowledge-sharing on specific themes.

06 Dec 2016

Acesion Pharma recruits an experienced life science Chief Financial Officer

Acesion Pharma, a Danish biotech company developing novel treatments for atrial fibrillation (AF), announced that it has recruited Jakob Dynnes Hansen as its Chief Financial Officer to succeed Herik Moltke, who will continue as CFO of Scandinavian Micro Biodevices that was recently acquired by Zoetis.

Jakob joins Acesion from Evolva, a Swiss biotech company, where he has been CFO since 2007 and where he played a key role in the company’s public listing in 2009 and subsequent public financings. Prior to that Jakob was CFO of Nuevolution A/S and Zealand Pharma A/S and had senior roles at a Scandinavian investment bank and at Novo Nordisk A/S. Jakob will also continue to perform srvices for Evolva while the company is transitioning to a new CFO.

    If you cannot find what you are looking for or if you have feedback to our website, please do not hesitate to contact ps@danskbiotek.dk or +45 7172 1114

    Copyright 2016 DANISH BIO – DANSK BIOTEK. All rights reserved.